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unlixin67@yahoo.cAbstract The present study was aimed at the comparison of the pharmacokinetics of pure
chlorogenic acid and extract of Solanum lyratum Thunb. The animals were allocated to two groups,
and were administered chlorogenic acid or extract of S. lyratum Thunb. at a dose of 50.0 mg/kg
orally. Blood samples were collected up to 8 h post-dosing. Plasma chlorogenic acid analyses were
performed using an HPLC method with UV detector. The pharmacokinetic parameters were
evaluated using non-compartmental assessment. Signiﬁcant differences existed in the two groups
for AUC0t, AUC0N and CLz/F. The reliable HPLC method was successfully applied to the
determination of chlorogenic acid in rat plasma at dosage of 50.0 mg/kg.
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Solanum lyratum Thunb (Solanaceae) is one of the most
valued Chinese traditional medicines. It is well known as
‘‘Hedrba Solani Lyrati’’ in mainland of China, which has beenersity. Production and hosting
n Jiaotong University.
sevier
om (L.-X. Sun).used for regulating body immune function and ability [1–4].
It was also reported to have anticancer activity [5]. The plant
is known to contain steroidal glucuronides, steroidal alkaloid
glucosides, coumarin and phenolic acid, etc. [6–10].
Chlorogenic acid (3-O-caffeoylquinic acid) is composed of
quinic acid and caffeic acid. It is the major active component
of S. lyratum, and its amount could reach up to 3.0 mg/g [11].
The compound has a variety of biological activities such as
anti-microbes, anti-virus, oxidation prevention, anti-tumor
and anti-hypertension [12].
Several HPLC methods were developed for the pharmaco-
kinetic studies of chlorogenic acid [13–18]. Ren et al. [19]
reported that the pharmacokinetic behavior of chlorogenic
acid after oral administration has obvious difference among
different dosages (200, 400 and 600 mg/kg). It is well known
that the contents of active ingredients in traditional Chinese
medicine are usually low, so the studies of their pharmaco-
kinetic behavior at small dose (50.0 mg/kg) are important and
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change the pharmacokinetics of chlorogenic acid, and there
was no report related to this issue.
In this study, a reliable HPLC method was established to
determine the concentration of chlorogenic acid in rat plasma.
The pharmacokinetic behaviors between chlorogenic acid and
extract of S. lyratum after oral administration were compared. It
is important for understanding of the synergism of components
among S. lyratum and designing rational dosage regimens.2. Materials and methods
2.1. Chemicals and reagents
Chlorogenic acid (Fig. 1A) and the internal standard (IS),
puerarin (Fig. 1B), were provided by the National Institute
for the Control of Pharmaceutical and Biological Products
(Beijing, China). S. lyratum was purchased from Xuhui
Pharmaceutical Co. Ltd. (Shanghai, China) and was genuinely
identiﬁed by Prof. Qi-Shi Sun (Shenyang Pharmaceutical
University, China). Methanol (HPLC grade) and other analy-
tical grade reagents were obtained from Yuwang Reagent
Company (Shenyang, China).2.2. Instruments and chromatographic conditions
The HPLC system consisted of a Shimadzu LC-10A pump, an
SPD-10AV detector and a column oven. Data were processed
using Anastar software (Autoscience Instrument Co. Ltd., China).
The separation was performed on a Diamonsil-C18 column
(250 mm 4.6 mm, 5 mm). The mobile phase was methanol–
0.05% phosphoric acid (23:77, v/v) at a ﬂow rate of 1 mL/min.HO COOH
OOCC
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Figure 1 Chemical structure of chlorogenic acid (A) and
puerarin (B).UV detector was set at 327 nm and the column temperature was
maintained at 30 1C. The sample injection volume was 20 mL.
2.3. Preparation of standards
The working solution of chlorogenic acid was prepared at
concentrations over 0.250–75.0 mg/L in methanol. Quality
control (QC) solutions were prepared at 0.50, 2.50, 60.0 mg/L
in the same way. Internal standard working solution of
5.00 mg/L was prepared by dissolving the accurately weighed
puerarin in methanol. All the solutions were stored at 4 1C
away from light.
The calibration standards were prepared by spiking 100 mL of
blank plasma with 20 mL chlorogenic acid standard solution to
obtain ﬁnal serial concentrations of 0.0500, 0.100, 0.200, 0.500,
1.00, 2.00, 5.00 and 15.0 mg/L. QC samples were prepared at
concentrations of 0.100, 0.500 and 12.0 mg/L in the same manner.
2.4. S. lyratum extracts preparations
The dried and crushed herbs of S. lyratum (400 g) were extracted
with 90% ethanol under reﬂuxing three times for an hour per
time. The crude extract obtained by vacuum concentration was
subjected to absorbent resin (AB-8) column chromatography with
a gradient of ethanol in water. The ratios of ethanol used during
the procedure of column chromatography were 0, 20%, 40%,
60% and 90%, and initial eluant was water absolutely. LC with
UV detector was used to monitor the elution process of
chlorogenic acid. Chlorogenic acid (7.8 g) was separated from
fraction 1 (using water as elute) and fraction 2 (using 20% ethanol
as elute). The content of chlorogenic acid in the extractive was
15.1 mg/g detected by LC.
2.5. Plasma samples preparations
Plasma samples (100 mL) were spiked with 20 mL puerarin
(IS, 5.00 mg/L) and were acidiﬁed by adding 10 mL hydro-
chloric acid (0.8 mol/L). The mixture was extracted with 2 mL
isopropyl alcohol for 7 min. After centrifuged at 12,000 rpm
for 5 min, the supernatant was transferred to another tube and
evaporated to dryness under a stream of nitrogen at 40 1C.
The residue obtained was reconstituted in 50 mL mobile phase,
20 mL of which was injected into the HPLC system.
2.6. Method validation
Blank rat plasma obtained from six different sources was
processed and analyzed for the assessment of potential inter-
ferences with endogenous substances.
Calibration curves were constructed over the concentration
range of 0.0500–15.0 mg/L by plotting the observed peak area
ratios of chlorogenic acid and IS against known concentration
of chlorogenic acid. The results were ﬁtted to linear regression
analysis using 1/x2 as weighting factor. The lower limit of
quantiﬁcation (LLOQ) was estimated using signal to noise
ratio of 10.
The precision and accuracy were assessed by determining QC
samples at three concentration levels on three different days. The
accuracy was expressed by relative error (RE) and the precision
was deﬁned as the relative standard deviation (RSD).
W. Qi et al.272The extraction recovery of chlorogenic acid at three QC levels
was determined by comparing peak areas of chlorogenic acid with
those obtained from direct injection of the corresponding stan-
dards dissolved in the supernatant of the processed blank plasma.
The stability was evaluated by determining QC samples
(0.100, 0.500 and 12.0 mg/L) after storage at room tempera-
ture (25 1C) away from light for 24 h.
2.7. Pharmacokinetic study in rats
Male Wistar rats (240–260 g) were supplied by the Experi-
mental Animal Center of Shenyang Pharmaceutical Univer-
sity. They were kept under controlled conditions (room
temperature 2272 1C, relative humidity 50720%) for three
days before the experiment start. Before drug administration,
they were fasted overnight and allowed free access to water.
Animal experiments were carried out in accordance with the
Guidelines for Animal Experimentation of Shenyang Pharma-
ceutical University (Shenyang, China) and the procedure was
approved by the Animal Ethics Committee of this institution.
Male Wistar rats were divided into two groups (six rats each
group). The ﬁrst group was given oral administration of
chlorogenic acid at a dose of 50.0 mg/kg while the second
group was given 3.31 g/kg extract of S. lyratum (equal to
50.0 mg/kg chlorogenic acid) orally. Blood samples (0.3 mL)
were collected from the eye vein before (0 h) and 0.17, 0.33,
0.50, 0.75, 1.0, 2.0, 4.0, 6.0 and 8.0 h after administration into
heparinized tubes. These samples were immediately centri-
fuged at 3000 rpm for 10 min, and the plasma obtained was
stored at 20 1C until analysis.
2.8. Data analysis
Pharmacokinetic parameters were evaluated using non-compart-
mental assessment using the drug and statistics software (DAS,
version 2.0, Pharmacology Institute of China). The area under the
plasma concentration–time curve from zero to the time of the
last measurable sample (AUC0t) was calculated by the linear–
trapezoidal method. The area under the plasma concentration–
time curve from zero to inﬁnity (AUC0N) was estimated by
means of the trapezoidal rule with extrapolation to inﬁnity with
apparent elimination rate constant (Ke). The Ke was estimated by
log–linear regression of concentrations observed during the
terminal phase of elimination, and the corresponding elimination
half-life (t1/2) was then calculated as 0.693/Ke. The maximum
plasma concentration (Cmax) and their time of occurrence (Tmax)
were obtained directly from the measured data. Pharmacokinetic
parameters after oral administration of chlorogenic acid and
extract of S. lyratum were expressed as mean7SD and were
compared by a two one-sided t test using the Statistical Package
for the Social Science (SPSS, version 16.0). The signiﬁcant
difference was deﬁned as Po0.05.Figure 2 Chromatograms of chlorogenic acid in rat plasma.
A: blank plasma; B: plasma spiked with chlorogenic acid
(0.500 mg/L) and puerarin (IS, 2.50 mg/L); C: plasma sample 1 h
after oral administration of 50.0 mg/kg chlorogenic acid; D: plasma
sample 1 h after oral administration of extract of S. lyratum. Peak 1,
chlorogenic acid (18.5 min). Peak 2, puerarin (31.7 min).3. Results
3.1. Method validation
Typical chromatograms of blank plasma, blank plasma spiked
with chlorogenic acid and IS, rat plasma sample 1 h after oral
administration of chlorogenic acid and rat plasma sample
1 h after oral administration of extract of S. lyratum are
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IS were 18.5 and 31.7 min, respectively. The biological matrix
did not interfere with the determination of chlorogenic acid
and IS.
The calibration curve of chlorogenic acid was linear in the
range of 0.0500–15.0 mg/L with a mean correlation coefﬁcient
(r) (n¼3) of 0.9982, a slope of 2.025 and an intercept of
4.498 102. The LLOQ obtained for the analyte was 0.0500
mg/L, with the RSD and RE of 7.6% and 9.1%, respectively.
The intra-day and inter-day precisions of chlorogenic acid
at low to high concentrations were better than 1.8% and
8.6%, respectively. The accuracy (RE) of chlorogenic acid
ranged from 6.8% to 1.8%. The results indicated that the
reproducibility of the method was acceptable.
The mean extraction recovery (n¼5) at three concentration
levels was 68.6%, 71.8% and 72.9%, and RSD was 7.2%,
4.2% and 5.1%. Mean recovery of the IS was 90.5% with the
RSD of 4.6% (n¼15).
Stability of chlorogenic acid in prepared samples at room
temperature (251C) away from light for 24 h was determined by
QC samples (n¼5) at three concentration levels. RE of the three
concentration levels was 3.6%, 5.3% and 8.5%, respectively.0
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Figure 3 Plasma concentration versus time proﬁles of chloro-
genic acid in rats (n¼6) after oral administration.
Table 1 Pharmacokinetic parameters after oral adminis-
tration of chlorogenic acid (50.0 mg/kg) and extract of
S. lyratum (equal to 50.0 mg/kg chlorogenic acid) (n¼6/
group).
Parameters Chlorogenic
acid (P.O.)
Extract of
S. lyratum
(P.O.)
AUC0t (mg h/L) 1.5070.91 0.7670.26
n
AUC0N (mg h/L) 1.6170.92 0.8370.27
n
t1/2 (h) 1.7070.24 1.770.2
Tmax (h) 0.4870.29 0.3670.07
CLz/F [L/(h kg)] 39717 65721n
Vz/F (L/kg) 97.5747 154733
Cmax (mg/L) 0.5570.22 0.3770.12
Ke (1/h) 0.4170.06 0.4170.19
nRepresent signiﬁcant difference or Po0.05.3.2. Pharmacokinetics study
Comparative pharmacokinetics of chlorogenic acid was
performed after oral administration of 50.0 mg/kg of chloro-
genic acid or extract of S. lyratum (equal to 50.0 mg/kg
chlorogenic acid) to rats. Pharmacokinetic parameters were
obtained using non-compartmental methods. The mean
plasma concentration–time curve proﬁles are illustrated in
Fig. 3 and their pharmacokinetic parameters are listed in
Table 1. Pharmacokinetic parameters after oral administration
of chlorogenic acid and extract of S. lyratum were compared
by two one-sided t test using SPSS program (version 16.0).
The AUC0t and AUC0N for extract of S. lyratum were
0.7670.26 and 0.8370.27 mg h/L, and were signiﬁcantly
lower than those obtained after administration of chlorogenic
acid. The clearance (CLz/F) for extract of S. lyratum was
65721 L/(kg h), which was signiﬁcantly higher than that after
administration of pure chlorogenic acid.4. Discussion
4.1. Optimization of plasma samples preparations
Reagents like methanol, acetonitrile and perchloric acid were
tested for protein precipitation; however, the recovery of
chlorogenic acid was low. Chlorogenic acid was a biprotic
acid with pKa1¼3.59, pKa2¼8.59, and was difﬁcult to extract
by liquid–liquid extraction in nearly neutral environment. So
variety of concentrations (0.4, 0.6, 0.8, 1.0, 1.2 mol/L) of
hydrochloric acid (10 mL) were tried to adjust pH of plasma
samples. The results indicated that recovery of chlorogenic
acid obviously increased with concentrations of hydrochloric
acid until 0.8 mol/L, and endogenous interference increased
signiﬁcantly when concentration of hydrochloric acid was
higher than 0.8 mol/L. Therefore, 10 mL of hydrochloric acid
(0.8 mol/L) was added to plasma samples during sample
preparation. Ethyl acetate, ethyl acetate–isopropanol (10:90,
v/v) and isopropanol were tested as extract solvent for
chlorogenic acid extraction from plasma samples. Isopropanol
gave the highest recovery of chlorogenic acid, and was ﬁnally
chosen as the extraction solvent.4.2. Pharmacokinetic study
The current HPLC method was developed and validated for
the determination of chlorogenic acid in rat plasma. The
pharmacokinetics of chlorogenic acid after oral administration
of pure chlorogenic acid and extract of S. lyratum was
compared. The main differences between the pharmacokinetic
data of the two groups reﬂected in the AUC0t, AUC0N and
CLz/F, suggesting that other compounds in S. lyratum may
prohibit the absorption of chlorogenic acid and accelerate the
elimination of chlorogenic acid in rats. This phenomenon was
reported for the ﬁrst time, and further investigation is already
in progress.
In addition, a second absorption peak appeared about 1 h
after oral administration in both of the two plasma
concentration–time curves, it may be caused by the reabsorp-
tion of hepatoenteral circulation. This phenomenon has not
been reported before.
W. Qi et al.274The major part of chlorogenic acid was not absorbed in the
proximal part of the gut and reached the large intestine where
it was hydrolyzed by the microﬂora [20,21]. Most of chloro-
genic acid was metabolized easily in intestine. The main
metabolites were benzoic acid, benzene propanoic acid and
cinnamic acid [22]. The information about the absorption and
metabolism of chlorogenic acid may relate to the reabsorption
of hepatoenteral circulation. Moreover, some other compo-
nents of S. lyratum in intestine could restrain the absorption of
chlorogenic acid.5. Conclusion
In conclusion, pharmacokinetic behaviors of chlorogenic acid
after oral dosing of chlorogenic acid and extract of S. lyratum
had signiﬁcant differences. The absorption and excretion of
chlorogenic acid can be inhibited by the interaction between
other components of S. lyratum. These conclusions could
provide references for further studies on developing new
dosage forms of S. lyratum. The results also conﬁrmed the
theory that monomeric compound was unable to represent the
whole herb on the pharmacokinetic study of traditional
Chinese medicine. To get reliable and accurate results, tradi-
tional Chinese medicine should be investigated as a whole.
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